请输入您要查询的百科知识:

 

词条 O-1812
释义

  1. See also

  2. References

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 445942332
| IUPAC_name = (5Z,8Z,11Z,14Z)-20-cyano-N-[(2R)-1-hydroxypropan-2-yl]-16,16-dimethylicosa-5,8,11,14-tetraenamide
| image = O-1812_structure.png
| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
| IUPHAR_ligand = 732
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 342882-77-3
| ATC_prefix =
| ATC_suffix =
| PubChem = 9823107
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 7998855
| C=26 | H=42 | N=2 | O=2
| molecular_weight = 414.622 g/mol
| smiles = C[C@H](CO)NC(=O)CCC/C=C\\C/C=C\\C/C=C\\C/C=C\\C(C)(C)CCCCC#N
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C26H42N2O2/c1-24(23-29)28-25(30)19-15-12-10-8-6-4-5-7-9-11-13-16-20-26(2,3)21-17-14-18-22-27/h4-5,8-11,16,20,24,29H,6-7,12-15,17-19,21,23H2,1-3H3,(H,28,30)/b5-4-,10-8-,11-9-,20-16-/t24-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = WZQHSBKOWZOASP-QLZKPENWSA-N
}}O-1812 is an eicosanoid derivative related to anandamide that acts as a potent and highly selective agonist for the cannabinoid receptor CB1, with a Ki of 3.4 nM at CB1 and 3870 nM at CB2.[1] Unlike most related compounds, O-1812 is metabolically stable against rapid breakdown by enzymes, and produces a cannabinoid-like discriminative effect in rats, which is similar but not identical to that produced by cannabinoid drugs of other chemical classes.[2][3][4][5]

See also

  • AM-1235
  • AM-2232
  • AM-2389
  • Methanandamide
  • O-774
  • O-1057

References

1. ^{{cite journal |vauthors=Di Marzo V, etal |title=Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands |journal=Biochemical and Biophysical Research Communications |volume=281 |issue=2 |pages=444–51 |date=February 2001 |pmid=11181068 |doi=10.1006/bbrc.2001.4354 |url=}}
2. ^{{cite journal |vauthors=Baskfield CY, Martin BR, Wiley JL |title=Differential effects of Δ9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice |journal=The Journal of Pharmacology and Experimental Therapeutics |volume=309 |issue=1 |pages=86–91 |date=April 2004 |pmid=14718593 |doi=10.1124/jpet.103.055376 }}
3. ^{{cite journal |vauthors=Wiley JL, etal |title=A comparison of the discriminative stimulus effects of Δ9-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats |journal=Experimental and Clinical Psychopharmacology |volume=12 |issue=3 |pages=173–9 |date=August 2004 |pmid=15301634 |doi=10.1037/1064-1297.12.3.173 }}
4. ^{{cite journal |vauthors=Wiley JL, Smith FL, Razdan RK, Dewey WL |title=Task specificity of cross-tolerance between Δ9-tetrahydrocannabinol and anandamide analogs in mice |journal=European Journal of Pharmacology |volume=510 |issue=1-2 |pages=59–68 |date=March 2005 |pmid=15740725 |doi=10.1016/j.ejphar.2005.01.006 }}
5. ^{{cite journal |vauthors=Breivogel CS, etal |title=Sensitivity to Δ9-tetrahydrocannabinol is selectively enhanced in β-arrestin2 -/- mice |journal=Behavioural Pharmacology |volume=19 |issue=4 |pages=298–307 |date=July 2008 |pmid=18622177 |pmc=2751575 |doi=10.1097/FBP.0b013e328308f1e6 }}
{{Cannabinoids}}{{alkene-stub}}{{cannabinoid-stub}}

3 : Cannabinoids|Nitriles|Fatty acid amides

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/11/15 8:00:45